Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis (Q44114291)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2012

Language	Label	Description	Also known as
English	Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis	scientific article published in August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis (English)

1 reference

Europe PubMed Central

29 November 2017

0 references

Christa E Müller

12

1 reference

Europe PubMed Central

29 November 2017

author name string

Ulrich Flögel

1

1 reference

Europe PubMed Central

29 November 2017

Sandra Burghoff

2

1 reference

Europe PubMed Central

29 November 2017

Peter L E M van Lent

3

1 reference

Europe PubMed Central

29 November 2017

Sebastian Temme

4

1 reference

Europe PubMed Central

29 November 2017

Lisa Galbarz

5

1 reference

Europe PubMed Central

29 November 2017

Zhaoping Ding

6

1 reference

Europe PubMed Central

29 November 2017

Ali El-Tayeb

7

1 reference

Europe PubMed Central

29 November 2017

Sandra Huels

8

1 reference

Europe PubMed Central

29 November 2017

Florian Bönner

9

1 reference

Europe PubMed Central

29 November 2017

Nadine Borg

10

1 reference

Europe PubMed Central

29 November 2017

Christoph Jacoby

11

1 reference

Europe PubMed Central

29 November 2017

Wim B van den Berg

13

1 reference

Europe PubMed Central

29 November 2017

Jürgen Schrader

14

1 reference

Europe PubMed Central

29 November 2017

language of work or name

0 references

publication date

1 August 2012

1 reference

Europe PubMed Central

29 November 2017

Science Translational Medicine

1 reference

Europe PubMed Central

29 November 2017

4

1 reference

Europe PubMed Central

29 November 2017

146

1 reference

Europe PubMed Central

29 November 2017

146ra108

1 reference

Europe PubMed Central

29 November 2017

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Revolutionary change in rheumatoid arthritis management with biological therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Connexin37 protects against atherosclerosis by regulating monocyte adhesion

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Recent developments in adenosine receptor ligands and their potential as novel drugs

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Clinical utility of regadenoson for assessing fractional flow reserve.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

The role of adenosine receptors in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Hypoxia and inflammation

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Modeling the NF-κB mediated inflammatory response predicts cytokine waves in tissue

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Early assessment of pulmonary inflammation by 19F MRI in vivo

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Regulation of leukocyte function by adenosine receptors

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Identifiers

10.1126/SCITRANSLMED.3003717

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44114291&oldid=2106720599"